Alta Partners NextGen Fund II Management LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-27 4:30 pm Purchase | 2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA | Alta Partners NextGen Fund II Management LLC | 4,080,296 9.600% | 4,080,296 (New Position) | Filing |